Intragastric Balloon Market: Global Industry Analysis and Forecast (2022-2027) by Product, Filling Material, End-Use, and Region

Intragastric Balloon Market size was valued at US$ 87.3 Mn. in 2021 and the total Intragastric Balloon revenue is expected to grow at 12.1% through 2022 to 2027, reaching nearly US$ 173.24 Mn.

Intragastric Balloon Market Overview:

The parameters of the ideal intra-gastric balloon were determined by international specialists. A spherical silicone balloon that was saline-filled, soft, had a radio wave opaque indicator, and had a variable capacity between 395 and 495 cubic centimeters was detailed in their description. Intragastric balloons were supposed to be used for patients whose Body Mass Index didn't qualify them for operations but who still wanted to lose weight or get rid of an obesity-related ailment. Intragastric balloons might also be used for individuals with exceptionally high BMIs, to lessen the danger of surgical procedure, or when a patient is declared medically impaired. Global Intragastric Balloon Market To know about the Research Methodology :- Request Free Sample Report The trend toward simplicity of administration is obvious, and it's feasible that educated clinicians from a variety of specializations may be able to execute the treatment, perhaps in an ambulatory healthcare setting. We've seen new technologies in recent years that aim to make treatment easier by eliminating endoscopy and anesthesia. The current wireless, magnetism-assisted gastric capsule exemplifies the common technique, whereby technological improvements are blended into operations, although still in the early stages of research and design. In this report, the Intragastric Balloon market's growth reasons, as well as the market's many segments (Product, Filling Material, End-Use, and Region), are discussed. Data has been given by market players, regions, and specific requirements. This market report includes a comprehensive overview of all the significant improvements that are presently prevailing in all market segments. Key data analysis is presented in the form of statistics, infographics, and presentations. The study discusses the Intragastric Balloon market's Drivers, Restraints, Opportunities, and Challenges. The report helps to assess the market growth drivers and determines how to use these drivers as a tool. The report also helps to rectify and resolve issues related to the global Intragastric Balloon market situation.

Intragastric Balloon Market Dynamics:

The prevalence of obesity is the primary driving factor of the intragastric balloon market. Obesity is a huge public health issue all over the world. Over the projected period, the obesity crisis is predicted to worsen, supporting market growth. According to World Health Organization figures, almost 2.2 billion people were overweight, with around 760 million obese. Furthermore, it is predicted that by 2027, 2.9 billion people will be overweight and 1.2 billion will be obese. Given the high prevalence of obesity and the widespread acceptability of weight-loss surgical intervention e.g. gastric bypass by health practitioners, only 1.5% to 2.5% of the obese population is qualified for obesity-related operations, resulting in substantial obesity-related fatalities. For example, according to WHO figures, almost 2.79 million people worldwide die every year as a result of obesity or being overweight. This elevated mortality rate is expected to feed demand for less invasive treatments e.g. an intragastric balloon. Global Intragastric Balloon Market The intragastric balloon was added to the list of treatments and equipment authorized by the American Society for Metabolic Surgery as a treatment approach in 2017. The organization's approval and recommendation of this therapy are expected to promote the use of intragastric balloons. The rising prices and operational difficulties related to suction treatment are expected to drive up demand for intragastric balloons. Additionally, the advent of innovative intragastric balloons to address the drawbacks of traditional balloons is expected to drive market demand even higher. The magnetic smooth endoscopic intragastric balloon, for example, developed in partnership with Nanyang University, is a biomaterial, resistive to acids, and automaton system for losing weight, limiting any need for intricate implantation equipment and the possibility of harmful effects.

Intragastric Balloon Market Segment Analysis:

By Filling Material, the gas-filled intragastric balloon segment is expected to grow at a CAGR of 6.7% in the aforementioned forecast period. This is mainly due to the practical disadvantages offered by other methods e.g. liquid filling methods. The first form of an unwanted outcome includes the liquid-filled intragastric balloon over-inflating with air or extra fluid (spontaneous hyperinflation) in patients' abdomens, necessitating device removal prematurely. The onset of acute pancreatitis, which has also necessitated the untimely withdrawal of the device, is another kind of adverse outcome. In the United States, the Food and Drug Administration has received a number of reports of balloon over-inflation of liquid-filled devices. The Orbera Balloon System has been used the most, however, the ReShape Balloon System has also been used in this sort of event. Intense stomach pain, enlargement of the belly (stomach edema) with or without distress, breathing difficulties, and/or nausea were all indications of balloon over-inflation. To alleviate the patient's symptoms, the balloon may need to be removed prematurely. According to studies, balloon over-inflation can begin as little as 10 days after placement. These side effects make air-filled ballons a preferred choice by most obese patients.

Intragastric Balloon Market Regional Insights:

Because of its growing obese population and high acceptance of weight reduction therapies, North America is likely to have a substantial market position in the worldwide intragastric balloon market. According to data supplied by the Organization for Economic Cooperation and Development, around 39.5% of the US population was obese in 2020, the highest in the world. According to data given by the Organization for Economic Cooperation and Development, in 2020-2018, 60.3% of the population aged 16 years or older in Canada was fat, whereas 76.3% of people aged 16 years or older in Mexico were obese. As a result, minimally invasive techniques are in great demand. This area's populace is more likely to accept new developments, fueling the growth of the regional market. Furthermore, favorable regulatory circumstances, healthcare spending, and the existence of well-established medical infrastructure are all driving the intraregional market's growth. As the outbreak harmed the country's affairs and standard of living, most procedures were avoided unless it was a necessity, negatively hurting the intragastric balloon industry. The objective of the report is to present a comprehensive analysis of the Intragastric Balloon market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Intragastric Balloon market dynamics, structure by analyzing the market segments and projecting the Intragastric Balloon market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Intragastric Balloon market make the report investor’s guide.

Intragastric Balloon Market Scope: Inquire before buying

Global Intragastric Balloon Market
Report Coverage Details
Base Year: 2020 Forecast Period: 2021-2027
Historical Data: 2016 to 2020 Market Size in 2020: US $ 87.3 Mn.
Forecast Period 2021 to 2027 CAGR: 12.1% Market Size in 2027: US $ 173.24 Mn.
Segments Covered: by Product • Single Balloon • Dual Balloon • Triple Balloon
by Filling Material • Saline Filled • Gas Filled
by End-Use • Hospitals • Ambulatory Surgical centers • Clinics

Intragastric Balloon Market, by Region

• North America • Europe • Asia Pacific • Middle East and Africa • South America

Intragastric Balloon Market Key Players

Endalis • Districlass Medical • Shandong Institute of Medical Instruments • Phagia Technologies, Inc. • Fengh Medical • Medicone • Districlass Medical SA • BAROnova Inc. • Tulip Medical • Silimed • ReShape Medical • PlenSat • Phagia Technologies • Obalon Therapeutics • Medsil • Life Partners Europe • Lexal Srl FAQs: 1. Which is the potential market for the Intragastric Balloon in terms of the region? Ans. North America is likely to have a substantial market position in the worldwide intragastric balloon market. 2. What are the opportunities for new market entrants? Ans. The rising prices and operational difficulties related to suction treatment 3. What is expected to drive the growth of the Intragastric Balloon market in the forecast period? Ans. The prevalence of obesity is the primary driving factor of the intragastric balloon market. 4. What is the projected market size & growth rate of the Intragastric Balloon Market? Ans. Intragastric Balloon Market size was valued at US$ 87.3 Mn. in 2021 and the total Intragastric Balloon revenue is expected to grow at 12.1% through 2022 to 2027, reaching nearly US$ 173.24 Mn. 5. What segments are covered in the Intragastric Balloon Market report? Ans. The segments covered are Product, Filling Material, End-Use, and Region.
1. Global Intragastric Balloon Market: Research Methodology 2. Global Intragastric Balloon Market: Executive Summary 2.1 Market Overview and Definitions 2.1.1. Introduction to Global Intragastric Balloon Market 2.2. Summary 2.1.1. Key Findings 2.1.2. Recommendations for Investors 2.1.3. Recommendations for Market Leaders 2.1.4. Recommendations for New Market Entry 3. Global Intragastric Balloon Market: Competitive Analysis 3.1 MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2 Consolidation in the Market 3.2.1 M&A by region 3.3 Key Developments by Companies 3.4 Market Drivers 3.5 Market Restraints 3.6 Market Opportunities 3.7 Market Challenges 3.8 Market Dynamics 3.9 PORTERS Five Forces Analysis 3.10 PESTLE 3.11 Regulatory Landscape by region • North America • Europe • Asia Pacific • The Middle East and Africa • Latin America 3.12 COVID-19 Impact 4. Global Intragastric Balloon Market Segmentation 4.1 Global Intragastric Balloon Market, by Product (2022-2027) • Single Balloon • Dual Balloon • Triple Balloon 4.2 Global Intragastric Balloon Market, by Filling Material (2022-2027) • Saline Filled • Gas Filled 4.3 Global Intragastric Balloon Market, by End-Use (2022-2027) • Hospitals • Ambulatory Surgical centers • Clinics 5. North America Intragastric Balloon Market(2022-2027) 5.1 Global Intragastric Balloon Market, by Product (2022-2027) • Single Balloon • Dual Balloon • Triple Balloon 5.2 Global Intragastric Balloon Market, by Filling Material (2022-2027) • Saline Filled • Gas Filled 5.3 Global Intragastric Balloon Market, by End-Use (2022-2027) • Hospitals • Ambulatory Surgical centers • Clinics 5.4 North America Intragastric Balloon Market, by Country (2022-2027) • United States • Canada • Mexico 6. Asia Pacific Intragastric Balloon Market (2022-2027) 6.1. Asia Pacific Intragastric Balloon Market, by Product (2022-2027) 6.2. Asia Pacific Intragastric Balloon Market, by Filling Material (2022-2027) 6.2. Asia Pacific Intragastric Balloon Market, by End-Use (2022-2027) 6.2. Asia Pacific Intragastric Balloon Market, by Country (2022-2027) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 7. Middle East and Africa Intragastric Balloon Market (2022-2027) 7.1 Middle East and Africa Intragastric Balloon Market, by Product (2022-2027) 7.2. Middle East and Africa Intragastric Balloon Market, by Filling Material (2022-2027) 7.2. Middle East and Africa Intragastric Balloon Market, by End-Use (2022-2027) 7.4. Middle East and Africa Intragastric Balloon Market, by Country (2022-2027) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 8. Latin America Intragastric Balloon Market (2022-2027) 8.1. Latin America Intragastric Balloon Market, by Product (2022-2027) 8.2. Latin America Intragastric Balloon Market, by Filling Material (2022-2027) 8.2. Latin America Intragastric Balloon Market, by End-Use (2022-2027) 8.4 Latin America Intragastric Balloon Market, by Country (2022-2027) • Brazil • Argentina • Rest Of Latin America 9. European Intragastric Balloon Market (2022-2027) 9.1. European Intragastric Balloon Market, by Product (2022-2027) 9.2. European Intragastric Balloon Market, by Filling Material (2022-2027) 9.3. European Intragastric Balloon Market, by End-Use (2022-2027) 9.4. European Intragastric Balloon Market, by Country (2022-2027) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 10. Company Profile: Key players 10.1 Endalis 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2 Districlass Medical 10.3 Shandong Institute of Medical Instruments 10.4 Phagia Technologies, Inc. 10.5 Fengh Medical 10.6 Medicone 10.7 Districlass Medical SA 10.8 BAROnova Inc. 10.9 Tulip Medical 10.10 Silimed 10.11 ReShape Medical 10.12 PlenSat 10.13 Phagia Technologies 10.14 Obalon Therapeutics 10.15 Medsil 10.16 Life Partners Europe 10.17 Lexal Srl

About This Report

Report ID 10873
Category Healthcare
Published Date Nov 2019
Updated Date Feb 2022
Contact Us